Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Maximal percent inhibition (MPI) of selected HIV-1 subtype C Envs by maraviroc in 293-Affinofile CD4med/CCR5hi cells

From: Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc

Patient ID Env clone MPI (%)a SD (%)b
204 E-15 100.13 1.66
E-7 68.65 16.62
550 I-32 92.7 0.62
I-2 49.03 13.75
I-7 65.38 3.33
F-12 43.39 1.42
F-20 62.65 2.09
1375 E-21 100.01 0.69
E-2 16.54 10.53
I-8 30.87 9.17
1441 E-7 99.25 0.56
E-1 60.47 3.94
E-2 48.02 5.56
E-6 36.85 12.35
I-2 32.92 12.34
I-9 27.51 0.05
1684 I-13 100.27 1.46
E-7 72.63 2.91
2042 E-26 100.99 1.57
I-38 63.55 1.30
  1. MPI maximal percent inhibition, SD standard deviation
  2. aMean and b standard deviation of three independent experiments